[针对NMDAR/AMPAR:一种有前途的抑郁症药物治疗方法]
D V Kurkin1,2, E I Morkovin2, D A Bakulin1
1Russian University of Medicine, Moscow, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|June 17, 2024
概括
抑郁症的治疗受到单胺理论的限制. 探索谷氨基胺基通路为更有效的抑郁药物治疗提供了新的希望,通过准NMDA和AMPA受体.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 抑郁症是全球主要的健康问题,导致严重的残疾和影响工作能力.
- 长期存在的单胺抑郁症理论导致治疗效果有限的治疗方法.
- 需要替代的病理生理机制来改善抑郁症药物治疗.
研究的目的:
- 审查目前针对抑郁症的谷氨酸激活通路的药物.
- 探索谷氨酸基质调节的新进展,以提高抗抑郁药的有效性.
- 突出在中枢神经系统疾病中准谷氨类系统的潜力.
主要方法:
- 对现有和新兴的谷氨酸药物进行文献综述.
- 对NMDA和AMPA受体调节的临床前和临床数据的分析.
- 综合了关于谷氨酸对抑郁症的作用的信息.
主要成果:
- 包括NMDA和AMPA受体在内的谷氨基胺基通路在治疗抑郁症方面表现有前途.
- 现有具有谷氨酸活性的药物正在研究提高疗效.
- 目前正在开发针对谷氨酸类神经递质的新型治疗策略.
结论:
- 调节谷氨基基基路径代表了抑郁症药物治疗的前沿.
- 向NMDA和AMPA受体可以克服传统抗抑郁药物的局限性.
- 进一步研究谷氨酸激活机制可能会产生更有效的抑郁症治疗方法.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220
Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179
Antiepileptic Drugs: Glutamate Antagonists
319
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
319
Long-term Depression
30.8K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
120
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
120


